SPTX NASDAQ
Seaport Therapeutics, Inc. Common Stock
1W: -14.4%
1M: -26.1%
3M: -4.9%
YTD: -7.2%
$18.42
-0.53 (-2.80%)
Weekly Expected Move ±11.5%
$14
$16
$18
$21
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (50)
Seaport Therapeutics, Inc. $SPTX Shares Newly Acquired by State Street Corp
$SPTX stock is up 12% today. Here's what we see in our data. - Quiver Quantitative
Seaport Therapeutics (NASDAQ:SPTX) Stock Price Up 6.4% - Time to Buy? - MarketBeat
Seaport Therapeutics (NASDAQ:SPTX) Now Covered by Analysts at JonesTrading - MarketBeat
Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls
JonesTrading Initiates Coverage on Seaport Therapeutics With Buy Rating, $32 Price Target - marketscreener.com
Seaport Therapeutics (NASDAQ:SPTX) Sets New 52-Week High - Here's Why - MarketBeat
Seaport Therapeutics, Inc. - Common Stock (NQ: SPTX - The Chronicle-Journal
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO
Seaport Therapeutics' (SPTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Trv Gp Vi LLC Purchases New Holdings in Seaport Therapeutics, Inc. $SPTX - MarketBeat
Seaport Therapeutics (NASDAQ:SPTX) Reaches New 52-Week High - Here's What Happened - MarketBeat
PureTech Health (SPTX holder) discloses 31.2% Seaport Therapeutics stake - Stock Titan
Seaport Therapeutics (NASDAQ:SPTX) Reaches New 52-Week High - Here's What Happened - MarketBeat
Seaport Therapeutics (SPTX): Daphne Zohar discloses 5.23M-share, 9.1% beneficial stake - Stock Titan
Seaport Therapeutics (SPTX) insider Steven M. Paul reports 6.3% stake - Stock Titan
Seaport Therapeutics, Inc. GAAP EPS of -$1.78
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share - marketscreener.com
Seaport Therapeutics (SPTX) Earnings Date and Reports 2026 - MarketBeat
Price to earnings forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
SPTX Forecast — Price Target — Prediction for 2027 - TradingView
Insider Stock Purchases: June 24, 2026 - Quiver Quantitative
Insider Purchase: Director at $SPTX Buys 13,000 Shares - Quiver Quantitative
Insider Stock Purchases: June 24, 2026 - Moomoo
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Seaport Therapeutics, Inc. GAAP EPS of -$10.34
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
New oral anxiety drug aims to cut liver tests after early trial - Stock Titan
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
Seaport Therapeutics (SPTX) Stock Forecast and Price Target 2026 - MarketBeat
SPTX Initiated Coverage by JP Morgan -- Price Target Set at $42. - GuruFocus
Catalyst Watch: Fedspeak ramps up post-Powell, core PCE, and box office blitz
SPTX | Seaport Therapeutics, Inc. Common Stock Data, Price & News - Quiver Quantitative
Seaport Therapeutics, Inc. Common Stock (SPTX) Stock Price Today: $24.42 - Gotrade
Seaport Therapeutics (SPTX) Stock Trends and Sentiment 2026 - MarketBeat
Seaport Therapeutics Inc. (SPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move
Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move - Yahoo Finance
Seaport Therapeutics (SPTX) Stock Price, News & Analysis - MarketBeat
Hemab, Seaport surge as clinical-stage biotechs make trading debuts
Seaport, Hemab price upsized IPOs eyeing $550M in proceeds
Seaport Therapeutics Rings the Opening Bell - Nasdaq
SEAPORT THERAPEUTICS (SPTX) Stock News - Stock Titan
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
Drug developer Seaport Therapeutics seeks up to $212M in US IPO
SPTX Stock Price and Chart — NASDAQ:SPTX - TradingView
Neuropsychiatric drug developer Seaport files for U.S. IPO